News Search Results
Jan 22, 2026, 10:58 ET Global Optical Coherence Tomography (OCT) Market Projected To Reach USD 4.2 Billion by 2035 - Future Market Insights (FMI)
Aurora are expanding access to AI-enabled diabetic retinopathy screening in primary care settings.Ophthalmology Remains Core, New Segments ScaleOphthalmology is projected to maintain a 69.2% market share in 2025, driven by routine screening, disease monitoring, and
More news about: Future Market Insights
Jan 22, 2026, 10:50 ET Medical Image Management Market Surges to USD 10.2 Billion by 2033, Propelled by 9.8% CAGR - Verified Market Reports®
executives.Expanding Use Beyond Radiology: Non-radiology imaging volumes are growing faster than traditional imaging. Surgical imaging, ophthalmology, pathology digitization, and point-of-care ultrasound are driving new application developments and revenue streams for image management platforms.Regional
More news about: Verified Market Reports
Jan 22, 2026, 09:00 ET Verana Health Named Growth and Innovation Leader in 2025 Frost Radar™ for Life Sciences Real-World Evidence Solutions
patient data in oncology, COTA complements Verana Health data and technology offerings across ophthalmology, urology, and neurology. The company is an exclusive partner of the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) and the American Urological Association
More news about: Verana Health
Jan 22, 2026, 08:57 ET TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities
organizations spanning four continents1,400+ peer-reviewed publications across oncology, cardiology, neurology, and ophthalmology supported—double the 2024 total, bringing the cumulative count to 2,500+"These numbers represent accelerated hope for patients
More news about: TriNetX
Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
unmet need. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and supportive care, although it is not confined to these areas. Additional information can be found at
More news about: Specialised Therapeutics
Jan 21, 2026, 08:00 ET Samson Partners Expands Platform With Launch of Samson Partners Capital and Key Leadership Appointments
businesses through transformation, growth and successful exits. She currently serves as CEO of Leon Capital–backed Physician Directed Partners, an ophthalmology platform based in Atlanta and Nashville.Deutsch will continue in his role as founder and will also serve as executive coach with an emphasis
More news about: Samson Partners Capital
Jan 21, 2026, 07:30 ET Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition
need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with
More news about: Keenova Therapeutics
Jan 21, 2026, 02:49 ET TUM University Hospital adds pathology and ophthalmology to its Sectra enterprise imaging solution--boosts diagnostic efficiency for improved patient care
third quarter of Sectra's 2025/2026 fiscal year and includes the modules for pathology and ophthalmology. The solution is licensed to support up to 300,000 examinations per year.The pathology and ophthalmology modules are a part of Sectra's enterprise imaging solution which provides a unified strategy
More news about: Sectra
Jan 19, 2026, 08:00 ET FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
second product targeting early-onset Parkinson's disease, which entered Phase I trials in December 2023.NouvSight001: A breakthrough ophthalmology product that was granted Orphan Drug Designation (ODD) by the U.S. FDA in March 2024 for retinal degenerative diseases.These expanding
More news about: iRegene Therapeutics Co., Ltd
Jan 15, 2026, 14:07 ET Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
U.S. as well as global Emerging Markets. Sun Pharma's high-growth global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharma
Jan 15, 2026, 09:00 ET Verana Health Enhances Site Explorer Tool to Expedite Urology Clinical Trials
data (RWD), has launched updates to its Site Explorer application. Site Explorer now includes exclusive data from urology practices in addition to ophthalmology practices, expanding researchers ability to quickly find the study sites and model protocols, reduce recruitment timelines, and build enrollment
More news about: Verana Health
Jan 15, 2026, 09:00 ET Glaucoma Research Foundation to Honor Ophthalmology Leaders and Visionary Philanthropists at Annual Gala
long-standing commitment to GRF's sight-saving mission.The 2026 Visionary Award will be presented to Barbara Wirostko, MD, FARVO, an ophthalmology innovator, entrepreneur, and leader advancing the future of glaucoma care. With more than 30 years of experience in drug and device development,Oluwatosin
More news about: Glaucoma Research Foundation
Jan 14, 2026, 08:44 ET Holland Foundation for Sight Restoration Appoints Marjan Farid, M.D., and James Mazzo as Board Directors
building and leading organizations that set industry standards. Jim currently serves as Executive Chair of Neurotech Pharmaceuticals, President of the Ophthalmology Foundation and Board Chair of the Gavin Herbert Eye Institute and holds several board positions. His global reputation for building and running
More news about: Holland Foundation for Sight Restoration
Jan 14, 2026, 07:30 ET Keenova to Demonstrate Live Dupuytren's Contracture Treatment Procedure During American Association for Hand Surgery Meeting
need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with
More news about: Keenova Therapeutics
Jan 13, 2026, 20:18 ET Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
monoclonal antibody biosimilar. Our global pharmaceutical portfolio addresses a range of therapeutic areas including immunology, oncology, hematology, ophthalmology and endocrinology. Built on trust through our fully integrated capabilities – from advanced R&D and in-house manufacturing to a reliable global
More news about: Celltrion
Jan 13, 2026, 16:45 ET Keenova Announces New Dupuytren's Contracture Survey Presentation About Patient Perceptions and Treatment Outcomes
need, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology and urology. Globally headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with
More news about: Keenova Therapeutics
Jan 13, 2026, 09:07 ET 34 AMSURG Centers Named to Newsweek's 2026 List of America's Best Ambulatory Surgery Centers
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. Guided by its core values — Care Deeply, Champion Excellence, Cultivate Integrity and Celebrate Teamwork — AMSURG is committed
More news about: AMSURG Corporation
Jan 13, 2026, 09:00 ET 2025 VETTY Awards® Winners Exemplify Marketing Excellence in Animal Health Care Worldwide
Shepherd Agency. Category: Tradeshow Experience."The Equine Ophthalmology Program" by
More news about: North American Veterinary Community (NAVC)
Jan 13, 2026, 08:00 ET Conexiant Celebrates Milestone Anniversaries for 3 Vision Publications
2026 /PRNewswire/ -- Conexiant is pleased to announce the 30th anniversary of Ophthalmology Management as well as the 40th anniversaries of both Contact Lens Spectrum and Eyecare Business. Ophthalmology Management is a leading publication dedicated to supporting the clinical, surgical,
More news about: Conexiant
Jan 13, 2026, 06:19 ET RevitalVision, a Digital Therapeutic, Demonstrates Efficacy and Safety in Infantile Nystagmus
Positive clinical data published in British Journal of Ophthalmology show groundbreaking improvement in visual function in patients with infantile nystagmusDigital therapeutic provides a promising non-invasive treatment for improving visual function in patients with infantile nystagmus
More news about: RevitalVision
Jan 12, 2026, 17:31 ET Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight
more clearly defined, the persistent corneal edema market is set for substantial change. With high unmet need and rapid progress in regenerative ophthalmology, endothelial dysfunction is increasingly regarded as a treatable condition, paving the way for a new class of restorative, non-surgical therapies.Persistent
More news about: DelveInsight Business Research, LLP
Jan 12, 2026, 07:30 ET AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
Exchange and the STAR Market of the Shanghai Stock Exchange.RemeGen has built a highly differentiated pipeline across autoimmune, oncology and ophthalmology, with a proven ability to rapidly translate innovative science into clinically and commercially meaningful medicines. Its two flagship products,
More news about: AbbVie
Jan 12, 2026, 05:00 ET Windrose Consulting Group Expands Greater China and APAC Expertise with Acquisition of Zenith Access Network
across multiple therapeutic areas, including oncology, cardiovascular disease, neurology, endocrinology, infectious diseases, rare diseases, and ophthalmology. To learn more, visit zenith-access.com.About
More news about: Windrose Consulting Group
Jan 12, 2026, 05:00 ET Windrose Consulting Group Expands Greater China and APAC Expertise with Acquisition of Zenith Access Network
across multiple therapeutic areas, including oncology, cardiovascular disease, neurology, endocrinology, infectious diseases, rare diseases, and ophthalmology. To learn more, visit zenith-access.com.About Windrose Consulting
More news about: Windrose Consulting Group
Jan 12, 2026, 03:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
our relationship with Samil with the mutual goal to serve Korean ocular surgery patients. Samil's rich history and status of being a leader in ophthalmology will ensure that APP13007, poised to be the first ophthalmic steroid introduced since 2008, will reach its full potential." said Erick Co, President
More news about: Formosa Pharmaceuticals Inc.,